• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双唾液酸神经节苷脂GD2抗原在神经母细胞瘤细胞系球体上的分布及抗GD2抗体的结合情况

Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.

作者信息

Heiss P, Bermatz S, Wehnes H, Heinzmann U, Senekowitsch-Schmidtke R

机构信息

Nuklearmedizinische Klinik, Technischen Universität München, Germany.

出版信息

Anticancer Res. 1997 Jul-Aug;17(4B):3145-7.

PMID:9329622
Abstract

The ganglioside GD2 is highly expressed on human tumors of neuroectodermal origin. We investigated by scanning electron microscopy the ganglioside GD2 distribution on the surface of spheroids of the neuroblastoma cell line SK-N-LO. About 50% of cells showed GD2 on the plasma membrane and the distribution of GD2 on most of these cells was heterogeneous, with more GD2 at the contact sites of the cells. The binding kinetics of the chimeric anti-GD2 antibody ch14.18 labelled with I-125 on spheroids (average diameter: 450 microns) was determined by gamma counting. Over 4 hours the antibody concentration was raised substantially but up to 24 hours there was only a very slow further increase. A clustered pattern of bound chimeric anti-GD2 antibody ch14.18 was found on a cross-section of the spheroid by autoradiography.

摘要

神经节苷脂GD2在神经外胚层起源的人类肿瘤上高度表达。我们通过扫描电子显微镜研究了神经母细胞瘤细胞系SK-N-LO球体表面神经节苷脂GD2的分布。约50%的细胞在质膜上显示有GD2,并且这些细胞中大多数的GD2分布是不均匀的,在细胞的接触部位有更多的GD2。通过γ计数法测定了用I-125标记的嵌合抗GD2抗体ch14.18在球体(平均直径:450微米)上的结合动力学。在4小时内抗体浓度大幅升高,但直到24小时仅有非常缓慢的进一步增加。通过放射自显影在球体的横截面上发现了结合的嵌合抗GD2抗体ch14.18的聚集模式。

相似文献

1
Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.双唾液酸神经节苷脂GD2抗原在神经母细胞瘤细胞系球体上的分布及抗GD2抗体的结合情况
Anticancer Res. 1997 Jul-Aug;17(4B):3145-7.
2
Cytotoxic effect of immunoconjugate composed of glucose-oxidase coupled to an anti-ganglioside (GD2) antibody on spheroids.由与抗神经节苷脂(GD2)抗体偶联的葡萄糖氧化酶组成的免疫缀合物对球体的细胞毒性作用。
Anticancer Res. 1997 Jul-Aug;17(4B):3177-8.
3
Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.中国仓鼠卵巢细胞(CHO)产生的ch14.18抗体对小鼠神经母细胞瘤的抑制作用由自然杀伤细胞(NK细胞)介导。
Mol Immunol. 2005 Jul;42(11):1311-9. doi: 10.1016/j.molimm.2004.12.018. Epub 2005 Apr 7.
4
Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.通过用模拟表位肽疫苗接种诱导针对GD2碳水化合物肿瘤抗原的IgG抗体。
Eur J Immunol. 2006 May;36(5):1267-74. doi: 10.1002/eji.200535279.
5
Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).肿瘤反应性重组抗神经节苷脂GD2白细胞介素-2融合蛋白(ch14.18-IL2)对人效应细胞的激活作用。
Clin Cancer Res. 1996 Dec;2(12):1951-9.
6
Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen.神经母细胞瘤肿瘤抗原二唾液酸神经节苷脂GD2的肽模拟表位的分离与结构分析
Mol Immunol. 2005 Feb;42(3):319-25. doi: 10.1016/j.molimm.2004.07.011.
7
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.用嵌合抗GD2抗体增强抗体依赖性细胞毒性。
J Immunol. 1990 Feb 15;144(4):1382-6.
8
Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.从受限噬菌体展示肽库中筛选GD2神经节苷脂的新型肽模拟物。
Int J Mol Med. 2007 May;19(5):829-39.
9
Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.用抗神经节苷脂单克隆抗体靶向的含阿霉素免疫脂质体的细胞毒性
Anticancer Res. 1993 Mar-Apr;13(2):331-6.
10
Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.人神经母细胞瘤细胞上的双唾液酸神经节苷脂GD2:单克隆抗体介导的细胞溶解和肿瘤生长抑制的靶抗原。
Cancer Res. 1987 Feb 15;47(4):1098-104.

引用本文的文献

1
tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.肿瘤而非肿瘤衍生细胞系具有肾上腺素能谱系特征,GD2+,并且对抗 GD2 抗体治疗有反应。
Oncoimmunology. 2022 May 24;11(1):2075204. doi: 10.1080/2162402X.2022.2075204. eCollection 2022.